References
- 1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016 Sep;4(9):e609-16.
- 2. Cyranka M, Kapka-Skrzypczak L, Rzeski W. Chemoprewencja nowotworów – perspektywy zastosowania w profilaktyce i terapii. Zdr Publ 2009;119(2):223-7.
- 3. Szwejda-Grzybowska J. Antykancerogenne składniki warzyw kapustnych i ich znaczenie w profilaktyce chorób nowotworowych. Bromat Chem Toksykol 2011;4:1039-46.
- 4. Al-Gendy AA, Nematallah KA, Zaghloul SS, Ayoub NA. Glucosinolate profile, volatile constituents, antimicrobial, and cytotoxic activities of Lobularia libyca. Pharm Biol 2016;15(12):3257-63.
- 5. Wideł MS, Wideł M. Mechanizmy przerzutowania i molekularne mark-ery progresji nowotworów złośliwych. I. Rak jelita grubego. Post Hig 2006;60:453-70.
- 6. Śmiechowska A, Bartoszek A, Namieśnik J. Przeciwrakotwórcze właściwości glukozynolanów zawartych w kapuście (Brassica oleracea var. capitata) oraz produktów ich rozpadu. Post Hig 2008;62:125-40.
- 7. Walczak K, Marciniak S, Rajtar G. Chemoprewencja nowotworów – wybrane molekularne mechanizmy działania. Post Hig 2017;71:149-61.
- 8. Novio S, Cartea ME, Soengas P, Freire-Garabal M, Núñez-Iglesias MJ. Effects of Brassicaceae isothiocyanates of prostate cancer. Molecules 2016;21(5). pii: E626.
- 9. Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev 2005;14(9):2093-7.
- 10. Malczyk E, Majkrzak Ż. Żywieniowe czynniki rozwoju raka piersi. Probl Hig Epidemiol 2015;96(1):67-76.
- 11. Haschem FA., Motawea A, El-Shabrawy AE, Shaker K, El-Sherbini S. Myrosinase hydrolysates of Brassica olareceae L. var. italica reduce the risk of colon cancer. Phytother Res 2012;26(5):743-7.
- 12. Chen YJ, Wallig MA, Jeffery EH. Dietary broccoli lessens development of fatty liver and liver cancer in mice given diethylnitrosamine and fed a Western or control diet. J Nutr 2016;146(3):542-50.
- 13. Tomczyk J, Olejnik A. Sulforafan – potencjalny czynnik w prewencji i terapii chorób nowotworowych. Post Hig 2010;64:590-603.
- 14. Jakubíková J, Sedlák J, Mithen R, Bao Y. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem Pharmacol 2005;69(11):1543-52.
- 15. Pappa G, Bartsch H, Gerhäuser C. Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line. Mol Nutr Food Res 2007;51(8):977-84.
- 16. Park SY, Kim GY, Bae SJ, Yoo YH, Choi YH. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep 2007;18(1):181-7.
- 17. Wu J, Han J, Hou B, Deng C, Wu H, Shen L. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. Oncol Rep 2016;35(5):2977-83.
- 18. Ullah MF. Sulforaphane (SFN): an isothiocyanate in a cancer chemoprevention paradigm. Medicines (Basel) 2015;2(3):141-56.
- 19. Wagner AE, Boesch-Saadatmandi C, Dose J, Schultheiss G, Rimbach G. Anti-inflammatory potential of allyl-isothiocyanate – role of Nrf2, NF-κB and micro-RNA-155. J Cell Mol Med 2012;16(4):836-43.
- 20. Fuentes F, Paredes-Gonzalez X, Kong AT. Dietary glucosinolates sulforaphane, phenethyl isothiocyanate, indole-3-carbinol/3,3’-diindolyl-methane: anti-oxidative stress/inflammation, Nrf2, epigenetics/epigenomics and in vivo cancer chemopreventive efficacy. Curr Pharmacol Rep 2015;1(3):179-96.
- 21. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, et al. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: A histopathologic study of whole mount prostate specimens. Prostate 2004;60(1):25-31.
- 22. Caruso JA, Campana R, Wei C, Su CH, Hanks AM, Bornmann WG, et al. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells. Cell Cycle 2014;13(16):2587-99.
- 23. Dziurzyński S, Kultys J. Choroba wrzodowa wczoraj i dziś. Przegląd Medyczny Uniwersytetu Rzeszowskiego 2008;1:91-7.
- 24. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene induced stomach tumors. Proc Natl Acad Sci U S A 2002;99(11):7610-5.
- 25. Sotelo T, Lema M, Soengas P, Cartea ME, Velasco P. In vitro activity of glucosinolates and their degradation products against brassica-pathogenic bacteria and fungi. Appl Environ Microbiol 2015;81(1):432-40.
- 26. Piekarska A, Bartoszek A, Namieśnik J. Biofumigacja jako alternatywna metoda ochrony roślin. Ecological Chemistry and Engineering S 2010;17(4):527-47.